312 related articles for article (PubMed ID: 29595117)
1. Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.
Romana BS; Chela H; Dailey FE; Nassir F; Tahan V
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):547-554. PubMed ID: 29595117
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.
Filippatos TD; Alexakis K; Mavrikaki V; Mikhailidis DP
Dig Dis Sci; 2022 Jan; 67(1):26-41. PubMed ID: 33469809
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic fatty pancreas disease - practices for clinicians.
Pinte L; Balaban DV; Băicuş C; Jinga M
Rom J Intern Med; 2019 Sep; 57(3):209-219. PubMed ID: 30901317
[TBL] [Abstract][Full Text] [Related]
4. Non-Alcoholic Fatty Pancreas Disease: The Unsung Disease.
Sevim BC; Chela H; Ertugrul H; Malik LS; Malik S; Basar O; Daglilar E; Samiullah S; Gaballah AH; Tahan V
Endocr Metab Immune Disord Drug Targets; 2023; 23(4):485-493. PubMed ID: 36177623
[TBL] [Abstract][Full Text] [Related]
5. [Lipid accumulation in the pancreas: clinical significance of NAFPD (non-alcoholic fatty pancreas disease)].
Jermendy G
Orv Hetil; 2022 Oct; 163(44):1735-1742. PubMed ID: 36309887
[TBL] [Abstract][Full Text] [Related]
6. The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis.
Bi Y; Wang JL; Li ML; Zhou J; Sun XL
Diabetes Metab Res Rev; 2019 Jul; 35(5):e3142. PubMed ID: 30767421
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Fatty Pancreas Disease: Clinical Consequences.
Dite P; Blaho M; Bojkova M; Jabandziev P; Kunovsky L
Dig Dis; 2020; 38(2):143-149. PubMed ID: 31865317
[TBL] [Abstract][Full Text] [Related]
8. Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression.
Singh RG; Yoon HD; Wu LM; Lu J; Plank LD; Petrov MS
Metabolism; 2017 Apr; 69():1-13. PubMed ID: 28285638
[TBL] [Abstract][Full Text] [Related]
9. Impact of non-alcoholic fatty pancreas disease on glucose metabolism.
Yu TY; Wang CY
J Diabetes Investig; 2017 Nov; 8(6):735-747. PubMed ID: 28371475
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Fatty Pancreas Disease.
Shah N; Rocha JP; Bhutiani N; Endashaw O
Nutr Clin Pract; 2019 Oct; 34 Suppl 1():S49-S56. PubMed ID: 31535735
[TBL] [Abstract][Full Text] [Related]
11. [NON-ALCOHOLIC FATTY PANCREATIC DISEASE (NAFPD) AND THE METABOLIC SYNDROME: INITIATING FACTOR OR ADDITIONAL COMPONENT?].
Grigorieva IN; Efimova OV; Tov NL; Suvorova TS
Eksp Klin Gastroenterol; 2015; (9):86-91. PubMed ID: 26931016
[TBL] [Abstract][Full Text] [Related]
12. Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study.
Wu WC; Wang CY
Cardiovasc Diabetol; 2013 May; 12():77. PubMed ID: 23688357
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat.
Della Corte C; Mosca A; Majo F; Lucidi V; Panera N; Giglioni E; Monti L; Stronati L; Alisi A; Nobili V
Clin Endocrinol (Oxf); 2015 Nov; 83(5):656-62. PubMed ID: 26201937
[TBL] [Abstract][Full Text] [Related]
14. Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature.
Tariq H; Nayudu S; Akella S; Glandt M; Chilimuri S
Gastroenterology Res; 2016 Dec; 9(6):87-91. PubMed ID: 28058076
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty pancreas disease.
Alempijevic T; Dragasevic S; Zec S; Popovic D; Milosavljevic T
Postgrad Med J; 2017 Apr; 93(1098):226-230. PubMed ID: 28069746
[TBL] [Abstract][Full Text] [Related]
16. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease.
Catanzaro R; Cuffari B; Italia A; Marotta F
World J Gastroenterol; 2016 Sep; 22(34):7660-75. PubMed ID: 27678349
[TBL] [Abstract][Full Text] [Related]
17. Transabdominal ultrasonography of the pancreas is superior to that of the liver for detection of ectopic fat deposits resulting from metabolic syndrome.
Li S; Su L; Lv G; Zhao W; Chen J
Medicine (Baltimore); 2017 Sep; 96(37):e8060. PubMed ID: 28906401
[TBL] [Abstract][Full Text] [Related]
18. Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging.
Wong VW; Wong GL; Yeung DK; Abrigo JM; Kong AP; Chan RS; Chim AM; Shen J; Ho CS; Woo J; Chu WC; Chan HL
Am J Gastroenterol; 2014 Apr; 109(4):589-97. PubMed ID: 24492753
[TBL] [Abstract][Full Text] [Related]
19. The relationship between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non-alcoholic fatty liver disease.
Chiyanika C; Chan DFY; Hui SCN; So HK; Deng M; Yeung DKW; Nelson EAS; Chu WCW
Pediatr Obes; 2020 Sep; 15(9):e12653. PubMed ID: 32351030
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study.
Lesmana CR; Pakasi LS; Inggriani S; Aidawati ML; Lesmana LA
BMC Gastroenterol; 2015 Dec; 15():174. PubMed ID: 26652175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
